Skip to main content
Clinical Trials/ACTRN12607000470493
ACTRN12607000470493
Completed
Phase 3

A randomised controlled clinical trial to compare the efficacy of pressurised vapocoolant and water sprays in decreasing the pain of intravenous cannulation in emergency department patients.

Austin Health0 sites200 target enrollmentSeptember 19, 2007

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pain of intravenous cannulation
Sponsor
Austin Health
Enrollment
200
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 19, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Emergency department patients, aged 18 years or more, requiring intravenous cannulation.

Exclusion Criteria

  • Refusal to provide consent; Inability to provide informed consent (Non\-English speaking, altered mental state, significant illness); Moderate to severe discomfort or pain; Diseases of the skin associated with cold intolerance (eg: Raynaud’s phenomenon); Known allergy to spray contents; Peripheral neuropathy; Parenteral analgesia in the previous 4 hours

Outcomes

Primary Outcomes

Not specified

Similar Trials